Your Attention Please
Effects of glucagon-like peptide-1 receptor agonists on gastric mucosal visibility and retained gastric contents during esophagogastroduodenoscopy
How Ozempic Supports Weight Loss: Ozempic works by mimicking a natural hormone in your body that helps regulate blood sugar and appetite
California joined New Hampshire, Pennsylvania and South Carolina in ending coverage for adult obesity treatment, while other states are planning or considering restrictions
10.1038/onc.2017.38 Summary Keywords alcohol-associated liver disease (ALD), glucagon-like peptide 1 receptor agonists (GLP-1 RAs), metabolic dysfunction and alcohol-associated liver disease (MetALD), metabolic dysfunction-associated steatotic liver disease (MASLD), steatotic liver disease (SLD) Citation Mahalingam S, Kharbanda KK, Casey CA and Rasineni K (2026) Beyond diabetes and obesity: GLP-1 receptor agonists as multifunctional therapeutics across the steatotic liver disease spectrum
Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J